Načítá se...
Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension
Systemic arterial hypertension (SAH), a clinical syndrome characterized by persistent elevation of arterial pressure, is often associated with abnormalities such as microvascular rarefaction, defective angiogenesis, and endothelial dysfunction. Mesenchymal stem cells (MSCs), which normally induce an...
Uloženo v:
Vydáno v: | Stem Cells Int |
---|---|
Hlavní autoři: | , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Hindawi Publishing Corporation
2015
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4537741/ https://ncbi.nlm.nih.gov/pubmed/26300922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/685383 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|